Loading...

Anti-inflammatory Therapeutics Market is Expected to Reach $106.1 Billion, Globally, by 2020

 
 

quote The anti-inflammatory biologic hold the largest market share in 2014 and would also exhibit highest growth rate over the forecast period. This is due to the emergence of targeted anti-inflammatory biologics and biosimilars with lesser side effects. Market share of corticosteroids is projected to decrease by 2020, primarily due to withdrawal syndromes. Among indication market, arthritis would continue to lead through 2020 due to high incidence rate and preference of anti-inflammatory biologics for the treatment of arthritis. quote

Onkar Sumant

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

Anti-Inflammatory Therapeutics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $106.1 billion by 2020, registering a CAGR of 5.9% during the period 2015-2020. The anti-inflammatory biologic segment held 3/5th of overall market in 2014. The Asia Pacific market would exhibit the highest CAGR of 8.5% during the forecast period.

Access Full Summary at: https://www.alliedmarketresearch.com/anti-inflammatory-therapeutics-market

Inflammation is the mechanism of innate immunity, which eliminates the cause of injury. Sometimes, the body's defense system inappropriately triggers inflammation against its own cells, resulting in inflammatory autoimmune diseases. Reducing inflammation is one of the primary therapeutic strategies in acute as well as chronic diseases such as arthritis, psoriasis, and asthma. The rising incidences of autoimmune and respiratory conditions, extensive drug development pipeline, and increasing popularity of anti-inflammatory drugs with lesser side effects are the key factors driving the growth of the global anti-inflammatory therapeutics market. In addition, growing awareness about anti-inflammatory therapeutics and government initiatives, in the Asia pacific and LAMEA would further boost the market growth. However, adverse effects associated with long term consumption of drugs, namely NSAIDs and Corticosteroids would limit the market growth to a certain extent.

Key findings of Anti-inflammatory Therapeutics Market:

  • Arthritis indication was the major revenue generating segment in the global anti-inflammatory therapeutics market in 2014 followed by respiratory diseases
  • Psoriasis segment is the projected to grow at a CAGR of 8.1%, fastest among all
  • North America would continue to lead the market through 2020, currently accounts for about half of the global revenue
  • The U.S. accounted for about 5/6thof the North America anti-inflammatory therapeutics market revenue in 2014
  • Asia-Pacific is projected to be the fastest growing market

In developed economies, such as North America and Europe, branded drugs are preferred over generics whereas there has been a reverse trend in developing economies. This is evident from the fact that about 50% of the anti-inflammatory biologics market has its presence in the North America, whereas, Asia Pacific and LAMEA collectively accounted for 35% share in NSAIDs market as compared to about just 25% share of the branded biologics market in 2014.

Companies are adopting drug pipeline development and product launch as key strategies to overcome patent expiries of existing drugs and gain additional market share. Key companies profiled in the report are Pfizer Inc., Abbvie Inc., Johnson & Johnson, GlaxoSmithKline, Merck & CO., Inc. Novartis, F. Hoffman La Roche AG, Eli Lily and Company, AstraZeneca PLC. and Amgen.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Shaun Godinho
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Anti-Inflammatory Therapeutics Market by Indication (Arthritis, Respiratory diseases, Multiple sclerosis, Psoriasis, Inflammatory bowel disease) and Drug Class (Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory drugs (NSAIDs), Corticosteroids) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020 quote

View Report
 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Anti-inflammatory Therapeutics Market"
Purchase Enquiry